The expressions of both CXCL1 and CXCL2 are increased by chronic hypoxia in PC-3 prostate cancer cells [14] but reduced in SK-OV-3 ovarian adenocarcinoma and WM793B melanoma cells. Here, CXCL2 is linked to prostate carcinoma.